Zynerba Pharmaceuticals, Inc. Free Cash Flow 2015-2023 | ZYNE
Zynerba Pharmaceuticals, Inc. free cash flow from 2015 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Zynerba Pharmaceuticals, Inc. Annual Free Cash Flow |
| 2022 |
-23.18 |
| 2021 |
-33.51 |
| 2020 |
-41.76 |
| 2019 |
-34.95 |
| 2018 |
-32.68 |
| 2017 |
-25.96 |
| 2016 |
-20.55 |
| 2015 |
-10.00 |
| 2014 |
-3.56 |
| 2013 |
-0.12 |
| Zynerba Pharmaceuticals, Inc. Quarterly Free Cash Flow |
| 2023-06-30 |
-16.40 |
| 2023-03-31 |
-7.97 |
| 2022-12-31 |
-23.18 |
| 2022-09-30 |
-17.49 |
| 2022-06-30 |
-7.74 |
| 2022-03-31 |
0.15 |
| 2021-12-31 |
-33.51 |
| 2021-09-30 |
-25.67 |
| 2021-06-30 |
-15.62 |
| 2021-03-31 |
-8.29 |
| 2020-12-31 |
-41.76 |
| 2020-09-30 |
-34.71 |
| 2020-06-30 |
-22.02 |
| 2020-03-31 |
-11.14 |
| 2019-12-31 |
-34.95 |
| 2019-09-30 |
-27.43 |
| 2019-06-30 |
-16.39 |
| 2019-03-31 |
-9.55 |
| 2018-12-31 |
-32.68 |
| 2018-09-30 |
-26.35 |
| 2018-06-30 |
-19.40 |
| 2018-03-31 |
-10.38 |
| 2017-12-31 |
-25.96 |
| 2017-09-30 |
-19.22 |
| 2017-06-30 |
-15.40 |
| 2017-03-31 |
-7.72 |
| 2016-12-31 |
-20.55 |
| 2016-09-30 |
-15.02 |
| 2016-06-30 |
-9.38 |
| 2016-03-31 |
-4.70 |
| 2015-12-31 |
-10.00 |
| 2015-09-30 |
-6.77 |
| 2015-06-30 |
-3.53 |
| 2015-03-31 |
-1.92 |
| 2014-12-31 |
-3.56 |
| 2014-09-30 |
-2.09 |
| 2014-06-30 |
-0.66 |
| 2014-03-31 |
-0.29 |
